Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Journal of Geriatric Cardiology : JGC
|
March 23, 2022
Translational proteomics in cardiogenic shock: from benchmark to bedside
Oriol Iborra-Egea, Antoni Bayes-Genis
Frontiers in Cardiovascular Medicine
|
June 1, 2022
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
Oriol Iborra-Egea, Alberto Aimo, Antoni Bayes-Genis
Current Opinion in Critical Care
|
May 27, 2020
An outlook on biomarkers in cardiogenic shock
Oriol Iborra-Egea, Santi Montero, Antoni Bayes-Genis
Biomedicines
|
December 24, 2021
iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams
Daina Martínez-Falguera, Oriol Iborra-Egea, Carolina Gálvez-Montón
Frontiers in Cardiovascular Medicine
|
March 14, 2022
Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
Oriol Iborra-Egea, Cosme García-García, Antoni Bayés-Genís
European Heart Journal
|
November 14, 2019
Molecular signature of cardiogenic shock
Oriol Iborra-Egea, Ferran Rueda, Cosme García-García, et al.
Revista Espanola De Cardiologia (English Ed.)
|
November 26, 2018
Circulating MiRNA Dynamics in ST-Segment Elevation Myocardial Infarction-driven Cardiogenic Shock
Oriol Iborra-Egea, Ferran Rueda, Päivi Lakkisto, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 30, 2021
Porcine iPSC Generation: Testing Different Protocols to a Successful Application
Oriol Iborra-Egea, Daina Martínez-Falguera, Santiago Roura, et al.
NPJ Systems Biology and Applications
|
June 27, 2017
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
Oriol Iborra-Egea, Carolina Gálvez-Montón, Santiago Roura, et al.
Frontiers in Cardiovascular Medicine
|
July 28, 2022
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
Oriol Iborra-Egea, Alberto Aimo, Nicola Martini, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Journal of Geriatric Cardiology : JGC
|
March 23, 2022
Translational proteomics in cardiogenic shock: from benchmark to bedside
Oriol Iborra-Egea, Antoni Bayes-Genis
Frontiers in Cardiovascular Medicine
|
June 1, 2022
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
Oriol Iborra-Egea, Alberto Aimo, Antoni Bayes-Genis
Current Opinion in Critical Care
|
May 27, 2020
An outlook on biomarkers in cardiogenic shock
Oriol Iborra-Egea, Santi Montero, Antoni Bayes-Genis
Biomedicines
|
December 24, 2021
iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams
Daina Martínez-Falguera, Oriol Iborra-Egea, Carolina Gálvez-Montón
Frontiers in Cardiovascular Medicine
|
March 14, 2022
Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
Oriol Iborra-Egea, Cosme García-García, Antoni Bayés-Genís
European Heart Journal
|
November 14, 2019
Molecular signature of cardiogenic shock
Oriol Iborra-Egea, Ferran Rueda, Cosme García-García, et al.
Revista Espanola De Cardiologia (English Ed.)
|
November 26, 2018
Circulating MiRNA Dynamics in ST-Segment Elevation Myocardial Infarction-driven Cardiogenic Shock
Oriol Iborra-Egea, Ferran Rueda, Päivi Lakkisto, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 30, 2021
Porcine iPSC Generation: Testing Different Protocols to a Successful Application
Oriol Iborra-Egea, Daina Martínez-Falguera, Santiago Roura, et al.
NPJ Systems Biology and Applications
|
June 27, 2017
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
Oriol Iborra-Egea, Carolina Gálvez-Montón, Santiago Roura, et al.
Frontiers in Cardiovascular Medicine
|
July 28, 2022
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
Oriol Iborra-Egea, Alberto Aimo, Nicola Martini, et al.
Page
of 3